Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
104M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
6.31M
-
Shares change
-
+40.2K
-
Total reported value, excl. options
-
$4.35M
-
Value change
-
-$839
-
Put/Call ratio
-
0
-
Number of buys
-
7
-
Number of sells
-
-12
-
Price
-
$0.69
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2023
37 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q3 2023.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.31M shares
of 104M outstanding shares and own 6.09% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (3.88M shares), BlackRock Inc. (553K shares), VANGUARD GROUP INC (542K shares), GEODE CAPITAL MANAGEMENT, LLC (538K shares), MORGAN STANLEY (210K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (176K shares), STATE STREET CORP (124K shares), NORTHERN TRUST CORP (89.5K shares), Spectrum Asset Management, Inc. (NB/CA) (55.6K shares), and TWO SIGMA SECURITIES, LLC (28.2K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.